Homexin
PrivateLast Round
Accelerator
Aug 2, 2022
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Homexin operates in Healthcare & Life Sciences and is based in Taipei. Its latest recorded funding round was an Accelerator round in August 2022.
Homexin is a healthcare technology company that provides a digital platform for matching patients and families with qualified caregivers for hospital and in-home care.
Sector
Healthcare & Life Sciences
Verticals
Home & Lifestyle, Patient Engagement
Business Model
B2C
Customer Profile
Marketplace Commission
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Homexin Comparables
Compare Homexin with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GHS Advanced Inc. | 91% | |
| Care724 | 88% | |
| Ucarer | 86% |
For institutional investors. Book with your work email.
Homexin Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Aug 2, 2022 | ||||
| Seed | Feb 1, 2022 | ||||
| Accelerator | Aug 12, 2021 | ||||
| Accelerator | Jan 1, 2021 |
For institutional investors. Book with your work email.
Homexin Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AppWorks | Accelerator |
| Taipei Medical University Biomedical Accelerator | Accelerator |
| 500 Global | Seed |
| BE Health Ventures | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 111% MoM, reaching 25.9K.
- Jul 27, 2026
Monthly visitors grew 136% MoM, reaching 12.3K.
For institutional investors. Book with your work email.
Homexin Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Homexin's valuation, stock price, and market status.
Is Homexin a public or private company?
Homexin is a private company.
What is the current stock price of Homexin?
Homexin is a private company, so its shares have no public market price. Caplight tracks Homexin's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Homexin worth (valuation)?
Valuation information for Homexin is not publicly available.
Can I buy Homexin stock?
Homexin shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Homexin's last funding round?
Homexin's most recent funding round was Accelerator on August 2, 2022.
Who are the main investors in Homexin?
Key investors in Homexin include 500 Global.
Will Homexin IPO soon?
No public IPO plans have been announced for Homexin.
How can I track Homexin secondary market activity?
Caplight tracks bids, offers, and trades in Homexin's shares on secondary markets.